1. Anti-infection Metabolic Enzyme/Protease
  2. Fungal Cytochrome P450
  3. CYP51-IN-26

CYP51-IN-26 是一种 CYP51 抑制剂,其 IC50 值约为 0.40 μM。CYP51-IN-26 可根除耳念珠菌生物膜。CYP51-IN-26 在累积实验中显著改善细胞摄取能力。CYP51-IN-26 在 G. mellonellaD. melanogaster 模型中均能保护免受耳念珠菌感染。CYP51-IN-26 可用于真菌感染研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CYP51-IN-26

CYP51-IN-26 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

CYP51-IN-26 is a CYP51 inhibitor with an IC50 value of approximately 0.40 μM. CYP51-IN-26 eradicates C. auris biofilms. CYP51-IN-26 demonstrates significantly improved intracellular uptake in an accumulation assay. CYP51-IN-26 protects against C. auris infection in both G. mellonella and D. melanogaster models. CYP51-IN-26 can be used for research on fungal infections[1].

体外研究
(In Vitro)

CYP51-IN-26 (Compound 7) 在耳念珠菌菌株 TDG1912 中的积累水平显著高于 Fluconazole (HY-B0101)[1]
CYP51-IN-26 对以下菌株显示出抗真菌活性:C.albicans NCNCPF3281(0.125 μg/mL)、N.glabratus NCPF8018 (0.25 μg/mL)、C.tropicalis NCPF8760 (0.25 μg/mL)、C.parapsilosis NCPF3209 (0.125 μg/mL)、TDG19 12 (0.25 μg/mL)、TDG25 12 (0.06 μg/mL)、TDG11 02 (4 μg/mL)、TDG22 11 (0.5 μg/mL)、TDG25 06 (≤ 0.03 μg/mL)、NCPF89 84 (≤ 0.03 μg/mL)、NCPF8971 (≤ 0.25 μg/mL) 和 NCPF8977 (≤ 0.03 μg/mL)[1]
CYP51-IN-26 (0.03-64 μg/mL, 24 h) 显著降低生物膜生物量,表现出与 Voriconazole (HY-76200) 相当的清除活性[1]
CYP51-IN-26 (0-25 h) 在至少 6 小时的孵育时间内显示出对耳念珠菌 TDG1912 生长的抑制作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

CYP51-IN-26 (Compound 7) (10-50 mg/kg,局部注射,感染后 30 分钟注射一次) 在感染了耳念珠菌 (TDG1912) 的大蜡螟 (G. mellonella) 模型中显示出显著的抗真菌效果[1]
CYP51-IN-26 (5-50 mg/kg,局部注射,感染后 1 小时注射一次) 在感染耳念珠菌的黑腹果蝇模型中改善了存活率[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: G. mellonella larvae were injected with 10 μL of C.auris strain TDG1912 at 1 × 107 CFU/mL into the first left proleg[1]
Dosage: 10, 20, 50 mg/kg
Administration: Local injected once after infection 30 min
Result: Demonstrated significant antifungal efficacy at 50 mg/kg and 20 mg/kg doses.
Animal Model: D.melaogaster adults were injected with 10 nL of C.auris strain TDG1912 at a concentration of 2 × 1011 CFU/mL or 1 × 1012 CFU/mL into the dorsolateral thorax below the right wing hinge[1]
Dosage: 5, 20, 50 mg/kg
Administration: Local injected once after infection 1 h
Result: Improved survival at both 50 and 20 mg/kg compared to the untreated group.
分子量

433.43

Formula

C20H22F3N7O

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
CYP51-IN-26
目录号:
HY-174973
需求量: